BusinessPROVECTUS ANNOUNCES RESULTS FROM MECHANISM OF ACTION STUDY OF TOPICAL PH-10 FOR THE TREATMENT OF PSORIASISBy Nasdaq OMXNov 30, 2017, 11:00 AM UTC
BusinessNovan Acquires IP Rights to Treat Viral Malignancies with Nitric OxideBy Nasdaq OMXOct 18, 2017, 11:05 AM UTC
BusinessNovan Presents Preclinical Data from Inflammatory Skin Diseases ProgramBy Nasdaq OMXApr 27, 2017, 1:05 PM UTC
BusinessNovan Announces Preclinical Data Demonstrating Immunomodulatory Effect In VivoBy Nasdaq OMXNov 16, 2016, 2:05 PM UTC
